rEVO Biologics (GTCB) Inactive 10-Q2008 Q2 Quarterly report

Filed: 7 Aug 08, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Good

New words: accredited, Acquisition, add, adverse, adversely, advisory, antitrypsin, appeal, appointment, Article, ATIII, attached, awarded, Baldridge, bid, budget, Bulletin, cardiopulmonary, committed, Committee, compensation, compensatory, confidential, conformity, consecutive, consideration, contra, daily, Daniel, delist, delisted, delisting, demonstrated, description, discretion, discretionary, distribution, document, efficient, employed, employee, encourage, entirety, exemption, fail, fibrinogen, firm, foregoing, fully, Geraghty, Global, Group, guarantee, Harry, heparin, high, highly, holder, Japan, Landine, lending, letter, lieu, line, liquidity, listed, listing, LLC, LLP, long, low, lump, maintain, maintained, maintaining, Meade, Michael, milestone, minimum, Nasdaq, North, notification, NV, OTC, OVATION, Panel, Pharming, proceed, purpose, qualified, ratify, recent, refundable, regain, reserve, resistance, responsible, restricted, retention, reverse, Richard, Robert, Scotland, split, straight, sum, terminate, termination, thereunder, trading, twenty, unavailable, unchanged, unexpected, UNREGISTERED, unrelated, unsigned, vested, Vice, volatile, volume, warrant, Woloshen

Removed: accelerated, apparent, base, carrying, check, Comprehensive, contingent, critical, disclaim, disseminate, Employer, evaluate, event, experience, expressed, expressly, filer, historical, Identification, Important, increased, intend, intended, involve, law, licensed, limitation, make, making, mark, obligation, ongoing, par, past, practicable, preceding, predict, project, readily, recognition, reflect, reported, shell, shipment, shorter, speak, TRANSITION, uncertain, unknown, Washington

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

GTCB similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of GTC Biotherapeutics, Inc. (the “Company”) for the quarterly period ended June 29, 2008, as filed with the Securities and Exchange Commission on the date hereof, (the “Report”), each of the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: August 7, 2008		/s/ Geoffrey F. Cox
		Geoffrey F. Cox
		Chairman of the Board, President and Chief Executive Officer

Date: August 7, 2008		/s/ John B. Green
		John B. Green
		Senior Vice President, Chief Financial Officer and Treasurer